Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Janux Therapeutics Inc

JANX
48,00
-0,82 (-1,68%)
27 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/11/202415:00BWJanux Therapeutics to Host Virtual Event Discussing Updated..
14/11/202422:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:07EDGAR2Form 8-K - Current report
06/11/202422:01BWJanux Therapeutics Reports Third Quarter 2024 Financial..
01/11/202421:24EDGAR2Form 144 - Report of proposed sale of securities
01/11/202421:17EDGAR2Form 144 - Report of proposed sale of securities
31/10/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202422:51EDGAR2Form 144 - Report of proposed sale of securities
25/10/202422:44EDGAR2Form 144 - Report of proposed sale of securities
23/10/202423:59EDGAR2Form 144 - Report of proposed sale of securities
23/10/202423:39EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
23/10/202423:38EDGAR2Form 144 - Report of proposed sale of securities
18/10/202422:48EDGAR2Form 144 - Report of proposed sale of securities
18/10/202422:39EDGAR2Form 144 - Report of proposed sale of securities
16/10/202423:35EDGAR2Form 144 - Report of proposed sale of securities
16/10/202423:25EDGAR2Form 144 - Report of proposed sale of securities
28/9/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202423:05EDGAR2Form 144 - Report of proposed sale of securities
27/9/202422:51EDGAR2Form 144 - Report of proposed sale of securities
27/9/202422:24EDGAR2Form 144 - Report of proposed sale of securities
27/9/202422:05EDGAR2Form 144 - Report of proposed sale of securities
27/9/202422:01EDGAR2Form 144 - Report of proposed sale of securities
26/9/202423:35EDGAR2Form 144 - Report of proposed sale of securities
26/9/202423:13EDGAR2Form 144 - Report of proposed sale of securities
13/9/202403:18EDGAR2Form 144 - Report of proposed sale of securities
13/9/202403:07EDGAR2Form 144 - Report of proposed sale of securities
11/9/202400:32EDGAR2Form 144 - Report of proposed sale of securities
11/9/202400:26EDGAR2Form 144 - Report of proposed sale of securities
07/9/202401:17EDGAR2Form 144 - Report of proposed sale of securities
10/8/202401:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/8/202422:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:20EDGAR2Form 8-K - Current report
07/8/202422:01BWJanux Therapeutics Reports Second Quarter 2024 Financial..
22/7/202423:00EDGAR2Form 8-K - Current report
22/7/202422:01BWJanux Therapeutics Announces Updates to Board of Directors
17/6/202423:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/6/202401:02EDGAR2Form 144 - Report of proposed sale of securities
08/5/202415:13EDGAR2Form S-3ASR - Automatic shelf registration statement of..
07/5/202422:01BWJanux Therapeutics Reports First Quarter 2024 Financial..
08/3/202422:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202422:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202422:11EDGAR2Form 8-K - Current report
08/3/202422:01BWJanux Therapeutics Reports Fourth Quarter and Full Year 2023..
29/2/202423:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202423:11EDGAR2Form 8-K - Current report
29/2/202407:22BWJanux Therapeutics Announces Pricing of $296.5 Million..
29/2/202403:55EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
Apertura: 48,82 Min: 47,70 Max: 49,74
Chiusura: 48,82

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network